Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

139 results about "Nucleic acid hybridisation" patented technology

Nucleic acid hybridization: A technique in which single-stranded nucleic acids (DNA or RNA) are allowed to interact so that complexes called hybrids are formed by molecules with similar, complementary sequences.

High performance fluorescence imaging module for genomic testing assay

Nucleic acid hybridization buffer formulations and uses thereof are described that yield improvements in hybridization specificity, rate, and efficiency. The buffer formulation composition includes a target nucleic acid; at least one polar, aprotic, organic solvent, and a pH buffer system, wherein the target nucleic acid is attached to the surface via hybridization to a surface bound nucleic acid tethered to the surface, and wherein the hybridization of the target nucleic acid and surface bound nucleic acid has a high stringency and annealing rate.
Owner:ELEMENT BIOSCIENCES INC

Nucleic acid hybridization methods

Nucleic acid hybridization buffer formulations and uses thereof are described that yield improvements in hybridization specificity, rate, and efficiency. The buffer formulation composition includes a target nucleic acid; at least one organic solvent having a dielectric constant in the range of no greater than 115; and a pH buffer system, wherein the target nucleic acid is attached to the surface via hybridization to a surface bound nucleic acid tethered to the surface, and wherein the hybridization of the target nucleic acid and surface bound nucleic acid has a high stringency and annealing rate.
Owner:ELEMENT BIOSCIENCES INC

Multivalent binding composition for nucleic acid analysis

Multivalent binding compositions including a particle-nucleotide conjugate having a plurality of copies of a nucleotide attached to the particle are described. The multivalent binding compositions allow one to localize detectable signals to active regions of biochemical interaction, e.g., sites of protein-protein interaction, protein-nucleic acid interaction, nucleic acid hybridization, or enzymatic reaction, and can be used to identify sites of base incorporation in elongating nucleic acid chains during polymerase reactions and to provide improved base discrimination for sequencing and array based applications.
Owner:ELEMENT BIOSCIENCES INC

Universal nucleic acid probe design method based on hybridization thermodynamics and dynamics

The invention discloses a universal nucleic acid probe design method based on hybridization thermodynamics and kinetics, which comprises the following steps: 1) determining a target amplification region according to a fragment interval, generating a primer pair which meets the length requirement and covers a target fragment, calculating the Gibbs free energy change of nucleic acid hybridization by adopting an intelligent nucleic acid hybridization algorithm, and calculating the Gibbs free energy change of the target fragment according to the Gibbs free energy change; by combining chemical thermodynamics, kinetic parameters, sequence complementarity and enzymatic reaction characteristics, generating an optimal primer pair under a multi-dimensional constraint condition; and 2) on the basis of the generated optimal primer pair, generating a probe combination meeting a free energy difference threshold as a candidate pool, screening the probe combination with the highest objective function value from the candidate pool through an iterative process, and updating the candidate pool step by step until the primer pair and the probe combination with the highest objective function value are output. By introducing an intelligent algorithm and combining a thermodynamic model, a dynamic model and specificity evaluation, an optimal primer and probe combination is automatically generated, and the stability and reliability of design are ensured.
Owner:SHANGHAI JIAOTONG UNIV

Nucleic acid probe sets comprising stem region for sample analysis

The present disclosure relates, in some aspects, to methods and compositions for analyzing a biological sample. In some aspects, the methods comprise use of a probe set comprising a first and second polynucleotide which hybridize to a target nucleic acid in the biological sample and form a circularized probe. In some aspects, the methods and compositions provided herein improve the detection of nucleic acids in a biological sample.
Owner:10X GENOMICS INC

Methods and compositions for ligation and sample analysis

The present disclosure relates in some aspects to methods for analyzing a target nucleic acid in a biological sample (e.g., cell or tissue sample). In some aspects, provided herein are methods and compositions for analyzing a target nucleic acid in a ligation-based assay using one or more probes, and phosphorylation of one or more probes hybridized to a target nucleic acid is performed.
Owner:10X GENOMICS INC

Multivalent binding composition for nucleic acid analysis

Multivalent binding compositions including a particle-nucleotide conjugate having a plurality of copies of a nucleotide attached to the particle are described. The multivalent binding compositions allow one to localize detectable signals to active regions of biochemical interaction, e.g., sites of protein-protein interaction, protein-nucleic acid interaction, nucleic acid hybridization, or enzymatic reaction, and can be used to identify sites of base incorporation in elongating nucleic acid chains during polymerase reactions and to provide improved base discrimination for sequencing and array based applications.
Owner:ELEMENT BIOSCIENCES INC

Non-invasive in-vitro method for somatic mutation detection

The invention relates to an in-vitro method of detecting a somatic mutation in a human comprising the steps of, (i) providing for a human sample, preferably a blood sample from a subject, more preferably a plasma sample, or a serum sample or a buffy coat sample, (ii) preparing a first nucleic acid sequencing library from the nucleic acids present in said sample, (iii) hybridizing one or more TAC oligonucleotides from a first TAC oligonucleotide pool (TAC oligonucleotide-1) to said first nucleic acid library thereby isolating a first subset of library nucleic acid molecules, (iv) sequencing said first subset of library nucleic acid molecules and comparing the sequences determined to a human reference sequence, thereby creating a first group of putatively informative sequence variants (PISV1), (v) hybridizing one or more TAC oligonucleotides from a second smaller TAC oligonucleotide pool comprising TAC oligonucleotides (TAC oligonucleotide-2) which are specific for the nucleic acid molecules of said first group of putatively informative sequence variants, to said first library of nucleic acid molecules thereby isolating a second subset of library nucleic acid molecules, (vi) sequencing said second subset of library nucleic acid molecules and comparing the sequences determined to a human reference sequence, thereby creating a second group of putatively informative sequence variants (PISV2), (vii) analyzing the putatively informative sequence variants (PISV2) thereby detecting a somatic mutation in the sample from the subject. Steps (i) to (iv) are also referred to together as step A. Steps (v) to (vii) are also referred to together as step B.
Owner:MEDICOVER BIOTECH LTD

Reagent compounds, compositions, kits, and methods for amplified assays

The instant disclosure provides reagent compounds, and antibody and oligonucleotide reagents, for use in a variety of assays, including immunoassays and nucleic acid hybridizations. The reagent compounds comprise a bridging antigen or bridging oligonucleotide and a latent crosslinker moiety, such as a tyramide moiety. The bridging antigens are recognizable by the antibody of a corresponding antibody reagent with high affinity, and the bridging oligonucleotides are complementary to the oligonucleotide of a corresponding oligonucleotide reagent. The antibody reagents and oligonucleotide reagents also comprise a crosslinker activation agent, such as a peroxidase enzyme. Reaction of the reagent compounds with the crosslinker activation agent results in the amplification of signal in assays for target cellular markers, including cellular antigens and nucleic acids. Also provided are detectable antibodies specific for the bridging antigens, kits comprising the reagent compounds and antibody and oligonucleotide reagents, methods of signal amplification using the compounds and reagents of the disclosure, methods of preparation of the compounds and reagents, and compositions comprising the compounds and reagents.
Owner:LEICA BIOSYST NEWCASTLE

Method of anchoring fragmented nucleic acid targets in polymer matrices for imaging

The present disclosure generally relates to methods for anchoring nucleic acids in a matrix and subsequently imaging nucleic acid targets (e.g., RNA transcript molecules) within a tissue sample, such as a formalin-fixed paraffin embedded (FFPE) tissue section, wherein the nucleic acids may be fragmented. For example, provided herein is a method of anchoring a target nucleic acid within a matrix and cleaning non-target cellular components and comprising contacting a tissue sample with at least two anchoring agents wherein the first anchoring agent forms a covalent bond with the target nucleic acid and the second anchoring agent contains an oligonucleotide that hybridizes to the target nucleic acid; embedding the sample in a polymer matrix, wherein the first anchoring agent and the second anchoring agent each form a covalent bond with the polymer matrix; and cleaning the non-target cellular fraction from the polymer matrix wherein the target nucleic acid remains anchored in the polymer matrix to form a matrix anchored target nucleic acid sample. Additional steps include contacting the anchored target nucleic acid sample with one or more primary oligonucleotide probes, the one or more primary oligonucleotide probes hybridizing to the target nucleic acid and a plurality of secondary nucleic acid probes, the secondary nucleic acid probe contains a fluorescent label and a recognition sequence hybridized with the sequence of the primary nucleic acid probe; and imaging the target nucleic acid.
Owner:VIZGEN INC

Multivalent binding composition for nucleic acid analysis

Multivalent binding compositions including a particle-nucleotide conjugate having a plurality of copies of a nucleotide attached to the particle are described. The multivalent binding compositions allow one to localize detectable signals to active regions of biochemical interaction, e.g., sites of protein-protein interaction, protein-nucleic acid interaction, nucleic acid hybridization, or enzymatic reaction, and can be used to identify sites of base incorporation in elongating nucleic acid chains during polymerase reactions and to provide improved base discrimination for sequencing and array based applications.
Owner:ELEMENT BIOSCIENCES INC

Interlocking nucleic acids for target hybridization

Interlocking nucleic acids for target hybridization are described. The interlocking nucleic acids include individual nucleic acids having respective capture regions that hybridize to the target nucleic acid and interlocking regions that bind to each other. In an embodiment, the interlocking nucleic acids are part of a probe set that specifically binds to a target nucleic acid to permit capture of the target nucleic acid. In an embodiment, the interlocking nucleic acids may be part of a primer used for amplification of the target nucleic acid.
Owner:ILLUMINA INC

Methods for detecting glioblastoma in extracellular vesicles

In certain embodiments, the present invention provides a panel of probes associated with glioblastoma that hybridize to nucleic acid and kits that comprise a collection of panels of probes associated with glioblastoma. In certain embodiments, the present invention provides a method of detecting the presence of biomarkers associated with an increased risk of glioblastoma in a human subject. In certain embodiments, the present invention provides a method of treating a human subject for glioblastoma.
Owner:REGENTS OF THE UNIVERSITY OF MINNESOTA

Phosphoramidite compounds and methods for preparing synthetic nucleic acids

The present disclosure concerns phosphoramidite compounds useful for nucleic acid hybridization probes, the probes containing them, and related methods of use and preparation.
Owner:ENZO LIFE SCIENCES INC

Variant polypeptides for supporting adherent and long-term culture of hPSCs in vitro, their design and applications

The present invention discloses variant polypeptides that support the adherent growth and long-term culture of hPSCs in vitro, as well as their design and applications. The present invention designs variants with VN polypeptides as the object to obtain the variant polypeptides, and the content of the variants is selected from any one of the following: (1) a polypeptide composed of an amino acid sequence obtained by deletion, substitution, insertion, and / or addition of one or more amino acids in the amino acid sequence of the VN polypeptide and having the function of supporting the growth of human pluripotent stem cells; (2) a polypeptide composed of an amino acid sequence having more than 70% amino acid homology with the amino acid sequence of the VN polypeptide and having the same function as the VN polypeptide; (3) a polypeptide encoded by a nucleic acid that hybridizes with the nucleic acid encoding the amino acid sequence of the VN polypeptide under stringent conditions and having the same function as the VN polypeptide. Based on the simple design, high synthesis efficiency, economic applicability, and excellent performance of the RGD-containing variant polypeptides, the present invention can ideally support the adherent growth and long-term amplification of hPSCs in vitro.
Owner:LANZHOU UNIV

Systems and methods for transposing cargo nucleotide sequences

The present disclosure provides systems and methods for transposing a cargo nucleotide sequence into a target nucleic acid site in a target nucleic acid. These systems and methods may comprise a double-stranded nucleic acid comprising the cargo nucleotide sequence, wherein the cargo nucleotide sequence interacts with a transposase recognition complex, an effector complex comprising an effector and at least one engineered guide polynucleotide that hybridizes to the target nucleic acid, and the transposase recognition complex wherein the transposase recognition complex recruits the cargo nucleotide to the target nucleic acid site.
Owner:METAGENOMI INC

Multivalent DNA nanowire logic device coupled DNA Walker nanomachine for detecting membrane local marker, and preparation method and application of multivalent DNA nanowire logic device coupled DNA Walker nanomachine

The invention relates to a multivalent DNA nanowire logic device coupled DNA Walker nanomachine for detecting a membrane local marker, and a preparation method and application thereof, which can effectively detect the interaction between miRNA released by cell injury and specific recognition cells as well as between tumor cells CEM and immune cells NK. A main body framework of the DNA Walker nano machine is of a triangular prism structure synthesized by PCR (Polymerase Chain Reaction), the lower end of the triangular prism structure comprises three nucleic acid chains with cholesterol, and the upper end of the triangular prism structure comprises a DNAzyme chain combined with a Block chain and two substrate chains; the multivalent DNA nanowire is subjected to hybrid chain reverse synthesis by an initiation chain, two hairpin chains H1 and H2, a complementary chain nucleic acid aptamer chain of H1 and a complementary chain logic chain of H2, a nucleic acid chain connected with cholesterol, DNAzyme and a substrate chain are modified through PCR synthesis of a TP structure and nucleic acid hybridization reaction, the multivalent DNA nanowire is suitable for detecting miRNA released by liver injury, and the economic and social benefits are remarkable.
Owner:ZHENGZHOU UNIV

Methods for cellularly addressable nucleic acid sequencing

Multivalent binding compositions including a particle-nucleotide conjugate having a plurality of copies of a nucleotide attached to the particle are described. The multivalent binding compositions allow one to localize detectable signals to active regions of biochemical interaction, e.g., sites of protein-protein interaction, protein-nucleic acid interaction, nucleic acid hybridization, or enzymatic reaction, and can be used to identify sites of base incorporation in elongating nucleic acid chains during polymerase reactions and to provide improved base discrimination for sequencing and array based applications.
Owner:ELEMENT BIOSCIENCES INC

Multivalent assemblies for enhanced target hybridization

Multivalent assemblies for target hybridization are described. The multivalent assemblies include oligonucleotide sets that hybridize to a target nucleic acid to permit capture of the target nucleic acid. In an embodiment, the multivalent assemblies are heteromultivalent such that the oligonucleotide sets include different oligonucleotides that bind to different regions of the target nucleic acid.
Owner:ILLUMINA INC

Method and device for extracting and / or reproducing a target nucleic acid

A method for extracting a target nucleic acid from a sample liquid includes providing a heating device having a heating element in contact with the sample liquid. The heating element is conjugated with at least one functional nucleic acid. The functional nucleic acid is adapted to hybridize to the target nucleic acid and bind the target nucleic acid to the heating element. Further, the method includes generating relative movement between the heating element and the sample liquid and extracting the target nucleic acid from the sample liquid by separating the heating element from the sample liquid.
Owner:HP HEALTH SOLUTIONS GERMANY GMBH

On-slide staining by primer extension

A method for analyzing planar sample is provided. In some cases the method comprises: (a) labelling the planar sample with a capture agent that is linked to a nucleic acid, wherein the capture agent specifically binds to complementary sites in the planar sample; (b) reading a fluorescent signal caused by extension of a primer that is hybridized to the nucleic acid, using fluorescence microscopy. Several implementations of the method, and multiplexed versions of the same, are also provided.
Owner:THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV

Fusion protein

The present disclosure provides systems and methods for transposing a cargo nucleotide sequence into a target nucleic acid site in a target nucleic acid. These systems and methods can include: a double-stranded nucleic acid comprising the cargo nucleotide sequence, where the cargo nucleotide sequence is configured to interact with a recombinase or transposase complex; an effector complex comprising an effector and at least one engineered guide polynucleotide configured to hybridize to the target nucleic acid; and the recombinase or transposase complex, wherein the recombinase or transposase complex is configured to recruit cargo nucleotides to the target nucleic acid site.
Owner:METAGENOMI THERAPEUTICS INC

Methods and compositions for influenza a virus subtyping

Disclosed herein are methods for detecting presence of a target nucleic acid (such as an influenza virus nucleic acid) in a sample. In some embodiments, the methods include contacting the sample with a first probe capable of hybridizing to the target nucleic acid and a second probe capable of hybridizing to the target nucleic acid, contacting the resulting complex with one or more gap filling reagents, thereby producing a gap-filled target nucleic acid, isolating and amplifying the gap-filled target nucleic acid. The amplified gap-filled target nucleic acid covalently linked to the substrate is then detected, for example with a detectably labeled probe. Also disclosed herein are probes capable of hybridizing to influenza virus nucleic acids. The disclosure also includes kits for detecting and / or discriminating influenza virus nucleic acids in a sample. In some examples, the kits include two or more of the disclosed probes.
Owner:THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES

Systems and methods for transposing cargo nucleotide sequences

The present disclosure provides systems and methods for transposing a cargo nucleotide sequence into a target nucleic acid site in a target nucleic acid. These systems and methods may comprise a double-stranded nucleic acid comprising the cargo nucleotide sequence, wherein the cargo nucleotide sequence interacts with a transposase recognition complex, an effector complex comprising an effector and at least one engineered guide polynucleotide that hybridizes to the target nucleic acid, and the transposase recognition complex wherein the transposase recognition complex recruits the cargo nucleotide to the target nucleic acid site.
Owner:METAGENOMI THERAPEUTICS INC

Conditionally activated cell membrane DNA tag as well as preparation method and application thereof

PendingCN119040316Aeliminate immunosuppressionEasy to prepareMicrobiological testing/measurementTumor/cancer cellsCholesterolMembrane insertion
The invention relates to a condition-activated cell membrane DNA tag and a preparation method and application thereof, can effectively realize controllable, specific, stable and high-abundance tumor cell membrane surface modification, and adopts the technical scheme that the condition-activated cell membrane DNA tag is prepared by carrying out nucleic acid hybridization reaction on a membrane insertion module and a responsive closing module, the membrane insertion module comprises a DNA triangular prism and a single-stranded DNA modified by a membrane insertion group, and the membrane insertion group comprises cholesterol and a C18 chain; the responsive sealing module comprises responsive single-stranded DNA and a sealing group, the sealing group comprises streptavidin, BSA protein and magnetic beads, the preparation method is simple and easy to operate, the cell membrane DNA tag activated through the nucleic acid hybridization reaction assembly condition is suitable for detecting recurrence of various postoperative tumors, and the application prospect is wide. The method is suitable for realizing controllable, specific, stable and high-abundance tumor cell membrane surface modification, and has remarkable economic and social benefits.
Owner:ZHENGZHOU UNIV

Cas proteins, crisper-cas systems, and applications thereof

A CRISPR-Cas system and applications thereof are provided, also related to a Cas protein, a fusion protein and a guide polynucleotide. The Cas protein has at least 50% sequence identity compared to the sequence set forth in any one of SEQ ID NOs: 1-184, 426-428. The fusion protein comprises the Cas protein fused to a protein domain and / or a polypeptide tag. The guide polynucleotide comprises a direct repeat sequence having at least 70% sequence identity to any one of SEQ ID NOs: 185-199, 245-247, 287-303, 369 and 370-373, and a guide sequence engineered to hybridize to a target nucleic acid. The CRISPR-Cas system comprises a Cas protein having at least 90% sequence identity compared to the sequence set forth in any one of SEQ ID NOs: 1-184, 426-428, or a nucleic acid encoding thereof, and a guide polynucleotide or a nucleic acid encoding thereof.
Owner:GUANGZHOU REFORGENE MEDICINE CO LTD +1

Systems and methods for transposing cargo nucleotide sequences

The present disclosure provides systems and methods for transposing a cargo nucleotide sequence into a target nucleic acid site in a target nucleic acid. These systems and methods can include: a double-stranded nucleic acid comprising the cargo nucleotide sequence, where the cargo nucleotide sequence is configured to interact with a recombinase complex; an effector complex comprising an effector and at least one engineered guide polynucleotide configured to hybridize to the target nucleic acid; and the recombinase complex, wherein the recombinase complex is configured to recruit the cargo nucleotide to the target nucleic acid site.
Owner:METAGENOMICS THERAPEUTICS CO